1. Home
  2. SMX vs TVGN Comparison

SMX vs TVGN Comparison

Compare SMX & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SMX (Security Matters) Public Limited Company

SMX

SMX (Security Matters) Public Limited Company

HOLD

Current Price

$1.86

Market Cap

18.8M

Sector

Technology

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$7.07

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SMX
TVGN
Founded
N/A
2020
Country
Ireland
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Blank Checks
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.8M
21.3M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
SMX
TVGN
Price
$1.86
$7.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 104.7K
4.3K
Earning Date
10-16-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$0.14
52 Week High
$490.00
$35.22

Technical Indicators

Market Signals
Indicator
SMX
TVGN
Relative Strength Index (RSI) 18.44 51.41
Support Level $1.02 $6.15
Resistance Level $19.84 $7.65
Average True Range (ATR) 0.84 0.55
MACD -0.06 0.00
Stochastic Oscillator 2.89 76.68

Price Performance

Historical Comparison
SMX
TVGN

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: